<--- Back to Details
First PageDocument Content
Chemistry / Liraglutide / Exenatide / Anti-diabetic medication / European Federation of Pharmaceutical Industries and Associations / Innovation / Organisation for Economic Co-operation and Development / Denmark / Magnesium in biology / Anti-diabetic drugs / Europe / Endocrine system
Date: 2013-04-12 03:23:25
Chemistry
Liraglutide
Exenatide
Anti-diabetic medication
European Federation of Pharmaceutical Industries and Associations
Innovation
Organisation for Economic Co-operation and Development
Denmark
Magnesium in biology
Anti-diabetic drugs
Europe
Endocrine system

Access to medicines - time for a progressive model Richard Bergström, EFPIA Director General 1

Add to Reading List

Source URL: www.efpia.eu

Download Document from Source Website

File Size: 1,99 MB

Share Document on Facebook

Similar Documents

Press Release  EBiSC – the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) join forces wi

Press Release EBiSC – the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) join forces wi

DocID: 1tXAK - View Document

EFPIA Disclosure Code: Your Questions Answered March 2016 #pharmadisclosure  www.efpia.eu

EFPIA Disclosure Code: Your Questions Answered March 2016 #pharmadisclosure www.efpia.eu

DocID: 1rsSj - View Document

European Federation of Biotechnology Microbial Physiology Section  The 2007 Annual meeting of the EFB Microbial Physiology Section was held aton Monday 17th September during ECB13, Fira de Barcelona in Barcelona,

European Federation of Biotechnology Microbial Physiology Section The 2007 Annual meeting of the EFB Microbial Physiology Section was held aton Monday 17th September during ECB13, Fira de Barcelona in Barcelona,

DocID: 1rnG2 - View Document

ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

DocID: 1rlyu - View Document

About the EFPIA Disclosure Code Securing the future of collaboration between industry and healthcare professionals Collaboration between industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) be

About the EFPIA Disclosure Code Securing the future of collaboration between industry and healthcare professionals Collaboration between industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) be

DocID: 1rkGi - View Document